[HTML][HTML] Control of human toxoplasmosis
Toxoplasmosis is caused by Toxoplasma gondii, an apicomplexan parasite that is able to
infect any nucleated cell in any warm-blooded animal. Toxoplasma gondii infects around 2 …
infect any nucleated cell in any warm-blooded animal. Toxoplasma gondii infects around 2 …
Bisphosphonates: the first 40 years
RGG Russell - Bone, 2011 - Elsevier
The first full publications on the biological effects of the diphosphonates, later renamed
bisphosphonates, appeared in 1969, so it is timely after 40 years to review the history of their …
bisphosphonates, appeared in 1969, so it is timely after 40 years to review the history of their …
Remarkable potential of the α-aminophosphonate/phosphinate structural motif in medicinal chemistry
R-Aminophosphonic acids are broadly defined as analogues of amino acids in which the
carboxylic group is replaced by a phosphonic acid or related group (usually phosphonous or …
carboxylic group is replaced by a phosphonic acid or related group (usually phosphonous or …
Bisphosphonates: from bench to bedside
RGG Russell - Annals of the New York Academy of Sciences, 2006 - Wiley Online Library
The discovery and development of the bisphosphonates (BPs) as a major class of drugs for
the treatment of bone diseases has been a fascinating journey that is still not over. In clinical …
the treatment of bone diseases has been a fascinating journey that is still not over. In clinical …
Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy
The bisphosphonates (BPs) are well established as the treatments of choice for disorders of
excessive bone resorption, including Paget's disease of bone, myeloma and bone …
excessive bone resorption, including Paget's disease of bone, myeloma and bone …
[LIVRE][B] Toxoplasma gondii: the model apicomplexan-perspectives and methods
LM Weiss - 2013 - books.google.com
This 2e of Toxoplasma gondii reflects the significant advances in the field in the last 5 years,
including new information on the genomics, epigenomics and proteomics of T. gondii as well …
including new information on the genomics, epigenomics and proteomics of T. gondii as well …
Bisphosphonates, old friends of bones and new trends in clinics
JS Barbosa, FA Almeida Paz… - Journal of Medicinal …, 2021 - ACS Publications
Bisphosphonates, used for a long time in osteoporosis management, are currently the target
of intensive research, from pre-formulation studies to more advanced stages of clinical …
of intensive research, from pre-formulation studies to more advanced stages of clinical …
Apicoplast isoprenoid precursor synthesis and the molecular basis of fosmidomycin resistance in Toxoplasma gondii
Apicomplexa are important pathogens that include the causative agents of malaria,
toxoplasmosis, and cryptosporidiosis. Apicomplexan parasites contain a relict chloroplast …
toxoplasmosis, and cryptosporidiosis. Apicomplexan parasites contain a relict chloroplast …
Toxoplasmosis: Current and emerging parasite druggable targets
RE Hajj, L Tawk, S Itani, M Hamie, J Ezzeddine… - Microorganisms, 2021 - mdpi.com
Toxoplasmosis is a prevalent disease affecting a wide range of hosts including
approximately one-third of the human population. It is caused by the sporozoan parasite …
approximately one-third of the human population. It is caused by the sporozoan parasite …
Metabolic pathways in the apicoplast of apicomplexa
F Seeber, D Soldati-Favre - International review of cell and molecular …, 2010 - Elsevier
Intracellular parasites of the phylum Apicomplexa harbor a plastid-like organelle called
apicoplast that is the most reduced organelle of this type known. Due to the medical …
apicoplast that is the most reduced organelle of this type known. Due to the medical …